SEC Form 4 · accession 0001209191-18-030094
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew A. Hindman
Officer — Chief Business Officer
Period of report
May 13, 2018
Accepted (ET)
May 15, 2018 · 7:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 13, 2018 | F | 3,930 | $24.35 | D | 47,118 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the number of shares of the issuer's Common Stock that were delivered to the issuer by the reporting person from vested restricted stock awards to cover tax liability in connection with vesting of those awards.